Briefly Bio
PrivateLast Round
Pre Seed
Jul 17, 2024
Total Funding Raised
$1.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Briefly Bio is a biotechnology company that provides an AI-powered experiment builder and collaborative platform to help scientists design, standardize, and share laboratory protocols.
Sector
Enterprise Software
Verticals
Biotechnology, Document Management, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Briefly Bio Comparables
Compare Briefly Bio with similar companies based on industry and business-model similarity.
Briefly Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 17, 2024 |
Briefly Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tiny Supercomputer Investment Company | Pre Seed |
| NP-Hard Ventures | Pre Seed |
| The Compound Capital Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 66% MoM, from 1.6K to 2.7K.
- Apr 16, 2026
Monthly visitors increased 46% MoM, reaching 2K.
Briefly Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Briefly Bio's valuation, stock price, and market status.